[Treatment approaches for bronchopulmonary infection in myasthenia gravis patients]

Autor:	Vi, Sokolova, Ag, Sanadze, Da, Sychev, Maria Babarina, Da, Zaĭkov
Předmět:	Adult Aged 80 and over Male Cefoperazone Immunoglobulins Intravenous Middle Aged Gram-Positive Bacteria Anti-Bacterial Agents Treatment Outcome Sulbactam Gram-Negative Bacteria Myasthenia Gravis Bronchopneumonia Pneumonia Bacterial Humans Drug Therapy Combination Female Aged
Zdroj:	Europe PubMed Central
Popis:	Nineteen patients with bronchopulmonary infection and myasthenia gravis were enrolled in the study. The microbiological analysis of the specimens of phlegm and bronchial secretion revealed both grampositive and gramnegative bacteria. All the isolates were susceptible to the antibiotic used (cefoperazone/sulbactam). Intravenous immunoglobulins (IvIgs) were used to increase the treatment efficacy, to opsonize the infection foci and to decrease the hospitalization terms. The antibiotic therapy and simultaneous use of intravenous immunoglobulins provided higher clinical efficacy in 16 out of 19 patients (84.2%).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d3d1b5c6b9a4d933c5e96bfc0ac99d31 http://europepmc.org/abstract/med/25051712 Zobrazit plný text záznamu